These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8152532)

  • 1. The quipazine- and TFMPP-increased conditioned avoidance response in rats: role of 5HT1C/5-HT2 receptors.
    Alhaider AA; Ageel AM; Ginawi OT
    Neuropharmacology; 1993 Dec; 32(12):1427-32. PubMed ID: 8152532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
    Herndon JL; Pierson ME; Glennon RA
    Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
    Arnt J
    Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW
    Pharmacol Biochem Behav; 1990 Jan; 35(1):181-5. PubMed ID: 2315357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
    Harel-Dupas C; Cloëz I; Fillion G
    J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
    Chaouloff F; Aguerre S; Mormede P
    Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
    Pranzatelli MR; Murthy JN; Tailor PT
    Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT1A receptor agonist flesinoxan shares discriminative stimulus properties with some 5-HT2 receptor antagonists.
    Herremans AH; van der Heyden JA; van Drimmelen M; Olivier B
    Pharmacol Biochem Behav; 1999 Oct; 64(2):389-95. PubMed ID: 10515319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).
    Cunningham KA; Appel JB
    J Pharmacol Exp Ther; 1986 May; 237(2):369-77. PubMed ID: 2939233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.